Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
Bernhard Hellmich, MD
Andreas Kronbichler, MD
Silke R. Brix, MD, MRCP, SCPR
Call to Action: Utilizing Avacopan to Improve AAV Care
Stephen McAdoo, MD
Incorporating Targeted Therapies in Treatment Planning for AAV
David Jayne, MD
Can We Do Better in IgAN?
Jonathan Barratt, PhD
Annette Bruchfeld, MD, PhD
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
Donald E. Kohan, MD, PhD
Case-Based Management of AAV
Updates in Glomerular Disease
Jürgen Floege, MD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.